Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Tiede

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
Haematologica|August 6, 2002
Cardiac surgery in a patient with paroxysmal nocturnal hemoglobinuriaKarsten Knobloch, Patrick Zardo, Bernhardt Gohrbandt, et al.
Blood|April 9, 2020
Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 studyKatharina Holstein, Xiaofei Liu, Andrea Smith, et al.
Blood Reviews|June 16, 2015
The use of recombinant activated factor VII in patients with acquired haemophiliaAndreas Tiede, Kagehiro Amano, Alice Ma, et al.
Haematologica|April 25, 2020
Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic modelAndreas Tiede, Faraizah Abdul Karim, Victor Jiménez-Yuste, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 2019
Investigation of the influence of xenoreactive antibodies on activation of complement and coagulation in an ex vivo perfusion animal study using porcine kidneysWolf Ramackers, Sonja Werwitzke, Johannes Klose, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 13, 2022
Safety of intramuscular COVID-19 vaccination in patients with haemophiliaAndreas Tiede, Hendrik Leise, Silvia Horneff, et al.
Annals of Hematology|June 19, 2017
Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Giovanni Di Minno, David Navarro, Carlo Federico Perno, et al.
Thrombosis and Haemostasis|December 5, 2021
Predictive Modeling Identifies Total Bleeds at 12-Weeks Postswitch to N8-GP Prophylaxis as a Predictor of Treatment ResponsePratima Chowdary, Kingsley Hampton, Victor Jiménez-Yuste, et al.
Journal of Thrombosis and Haemostasis : JTH|August 27, 2019
Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01/2010 StudyHalet Türkantoz, Christoph Königs, Paul Knöbl, et al.
Journal of Thrombosis and Haemostasis : JTH|January 12, 2024
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic reviewDavide Santagata, Alessia Abenante, Alessandro Squizzato, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
Haematologica|August 6, 2002
Cardiac surgery in a patient with paroxysmal nocturnal hemoglobinuriaKarsten Knobloch, Patrick Zardo, Bernhardt Gohrbandt, et al.
Blood|April 9, 2020
Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 studyKatharina Holstein, Xiaofei Liu, Andrea Smith, et al.
Blood Reviews|June 16, 2015
The use of recombinant activated factor VII in patients with acquired haemophiliaAndreas Tiede, Kagehiro Amano, Alice Ma, et al.
Haematologica|April 25, 2020
Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic modelAndreas Tiede, Faraizah Abdul Karim, Victor Jiménez-Yuste, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 2019
Investigation of the influence of xenoreactive antibodies on activation of complement and coagulation in an ex vivo perfusion animal study using porcine kidneysWolf Ramackers, Sonja Werwitzke, Johannes Klose, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 13, 2022
Safety of intramuscular COVID-19 vaccination in patients with haemophiliaAndreas Tiede, Hendrik Leise, Silvia Horneff, et al.
Annals of Hematology|June 19, 2017
Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Giovanni Di Minno, David Navarro, Carlo Federico Perno, et al.
Thrombosis and Haemostasis|December 5, 2021
Predictive Modeling Identifies Total Bleeds at 12-Weeks Postswitch to N8-GP Prophylaxis as a Predictor of Treatment ResponsePratima Chowdary, Kingsley Hampton, Victor Jiménez-Yuste, et al.
Journal of Thrombosis and Haemostasis : JTH|August 27, 2019
Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01/2010 StudyHalet Türkantoz, Christoph Königs, Paul Knöbl, et al.
Journal of Thrombosis and Haemostasis : JTH|January 12, 2024
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic reviewDavide Santagata, Alessia Abenante, Alessandro Squizzato, et al.
Pageof 13